Aurora Cannabis goes public on the New York Stock Exchange

Aurora Cannabis, one of the largest Canadian marijuana producers, is publicly public on the New York Stock Exchange. When Aurora's shares start trading on Tuesday morning, it will include a select list of cannabis producers listed on US-based exchanges.

While US-based exchanges were originally reluctant to list Canadian marijuana producers, companies such as Tilray (which conducted an initial public offer on NASDAQ in July), Cronos Group and Canopy Growth all now show up on US stock exchanges.

"We believe that the legalization in Canada provides a roadmap for investing in companies that will form the basis for the legal cannabis industry in the coming years," Jon Trauben, a managing partner of cannabis focused Altitude Investment Management, previously told Business Insider.

To be listed on a US exchange like NYSE, cannabis producers must prove that they do not violate any federal laws by importing cannabis into the United States except under special conditions.

: Some of the hottest companies in the thriving cannabis sector are hiring sprees as Canada's legal marijuana market opens

Aurora is currently trading on the Toronto Stock Exchange under ticker ACB. The Edmonton-based cultivator, or licensed producer, grows cannabis for both adult and medical markets.

Aurora's market value has increased over 1[ads1]00% since mid-August. On August 15, the drinking giant Constellation Brands announced that its share of 4 billion dollars in Aurora's rival, Canopy Growth, was announced.

From last week, marijuana is legal in Canada. However, legalization in Canada did not have the effect most investors had hoped for. Shares were traded as traders dumped shares. Aurora dropped over 12% on Monday in the follow-up to Tuesday's NYSE listing.

A staff member cuts cannabis plants in a laboratory at the head office of the AGES agency in Vienna, Austria, March 15, 2018.
REUTERS / Leonhard Foeger

Coca-Cola is looking to produce CBD-infused drinks with Aurora [19659012] Coca-Cola is apparently an agreement with Aurora to produce cannabidiol (CBD) beverages, a non-psychoactive ingredient in marijuana for the Canadian market.

None of the companies confirmed the rumors when they were contacted by Business Insider.

However, analysts and investors said they were not surprised to hear the rumors and told Business Insider that it would be a smart move on Coca Cola's part.

"We see highly-profiles, as well as institutional investors, wake up to opportunities in space," said Ben Kovler, CEO of the public Green Thumb Industries.

Challenges remain for companies in the cannabis industry. For one, banks are not willing to lend money to companies dealing with marijuana, as the plant is considered an illegal, Schedule I drug by the US federal government.

"The challenge is that until US government plans cannabis, companies like Coca-Cola will be hamstrung to produce innovative cannabis products with US operators," said Kevin Murphy, CEO of Acreage Holdings, who counts former politicians like John Boehner on the board, Said

Aurora also sees mad as Canada's legal marijuana market opens. The company has a total of 11 pages with posts on its website. These positions are based on Canada and range from senior leaders to laboratory research settings and industrial cleaners.

For some cannabis companies, a listing on a US based exchange is a golden ticket – but it will not be easier for companies to list until the federal government changes its position.

"Canada has this big finger waiting to point to us in USA, saying, "How do you not get along with your stuff?" Adam Bierman, CEO in the cannabis dispensary chain MedMen, told Business Insider.

Read more about Business Insider's cannabis industry coverage:

Source link

Back to top button